# 亲和色谱市场 > 亲和色谱市场研究报告按产品类型（配体类型、基质类型）、按应用（生物分子纯化、色谱分离）、按最终用户（制药和生物技术公司、研究机构、学术机构）和按地区（北美、欧洲、南美、亚太、中东和非洲） - 增长与行业预测2025至2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.48% - **2024:** $ 4.95 Billion - **2025:** $ 5.22 Billion - **2035:** $ 8.91 Billion - **Key Players:** Thermo Fisher Scientific (US), GE Healthcare (GB), Merck KGaA (DE), Bio-Rad Laboratories (US), Agilent Technologies (US), F. Hoffmann-La Roche (CH), Pall Corporation (US), Sartorius AG (DE), Waters Corporation (US) **Report ID:** MRFR/HC/27368-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** October 23, 2026 **URL:** https://www.marketresearchfuture.com/reports/affinity-chromatography-market-29074 --- ## Market Summary ## **Affinity Chromatography Market Overview:** As per MRFR analysis, the Affinity Chromatography Market Size was estimated at 4.95 (USD Billion) in 2024. The Affinity Chromatography Market Industry is expected to grow from 5.22 (USD Billion) in 2025 to 8.45 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.48% during the forecast period (2025 - 2034) **Key Affinity Chromatography Market Trends Highlighted** The Affinity Chromatography Market is witnessing a surge in demand due to the increasing prevalence of complex diseases and the growing need for efficient separation techniques. Advancements in biotechnology and the development of novel biomolecules are driving the adoption of affinity chromatography for biopharmaceutical production, diagnostics, and research applications. The market is also influenced by the trend towards personalized medicine, as affinity chromatography plays a crucial role in the development of targeted therapies and diagnostics. Furthermore, government initiatives and funding for biomedical research are expected to support the market's growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Affinity Chromatography Market Drivers** Advancements in Biotechnology and Pharmaceutical Research The Affinity Chromatography Market is primarily driven by the rapid advancements in biotechnology and pharmaceutical research. The increasing demand for novel and effective therapeutic modalities, such as monoclonal antibodies and recombinant proteins, has fueled the growth of affinity chromatography as a critical purification technique. Affinity chromatography enables the selective isolation and purification of target molecules from complex biological samples, which is essential for the development and manufacturing of biopharmaceuticals. The growing focus on personalized medicine and targeted therapies further contributes to the demand for affinity chromatography, as it allows for the isolation and analysis of specific biomarkers and analytes associated with various diseases. Rising Prevalence of Chronic Diseases and Cancer The increasing prevalence of chronic diseases and cancer worldwide is another key driver of the affinity chromatography market growth. Chronic conditions, such as diabetes, cardiovascular diseases, and autoimmune disorders, require ongoing monitoring and treatment, which often involve the analysis of specific biomarkers and proteins. Affinity chromatography plays a crucial role in the early detection, diagnosis, and monitoring of these diseases by enabling the accurate and sensitive detection of disease-specific biomarkers. Furthermore, the rising incidence of cancer has led to a growing demand for affinity chromatography-based techniques for cancer diagnostics and the development of targeted therapies. Technological Advancements and Automation The continuous advancements in technology and automation are also propelling the growth of the Affinity Chromatography Market. The development of automated affinity chromatography systems has significantly improved the efficiency, accuracy, and throughput of sample purification processes. These automated systems minimize human error, increase productivity, and allow for the processing of larger sample volumes. Moreover, the integration of artificial intelligence (AI) and machine learning (ML) algorithms is further enhancing the capabilities of affinity chromatography systems by optimizing purification protocols and reducing the time required for method development. **Affinity Chromatography Market Segment Insights:** **Affinity Chromatography Market Product Type Insights** The Affinity Chromatography Market segmentation by Product Type includes Ligand Type and Matrix Type. The Ligand Type segment is further classified into Protein A/G, Protein L, Heparin, IMAC, and Others. The Protein A/G segment holds the largest market share due to its high binding capacity and specificity for antibodies. The Matrix Type segment is further classified into Agarose, Polyacrylamide, and Others. The Agarose segment is expected to dominate the market due to its high porosity and biocompatibility. The Affinity Chromatography Market revenue from the Protein A/G ligand type is projected to reach USD 1.8 billion by 2024, growing at a CAGR of 5.4%. The increasing demand for monoclonal antibodies in the pharmaceutical and biotechnology industries is driving the growth of this segment. The Heparin ligand type is also expected to witness significant growth due to its affinity for heparin-binding proteins. In terms of Matrix Type, the Agarose segment is projected to account for over 60% of the Affinity Chromatography Market revenue by 2024. The high porosity and biocompatibility of agarose make it an ideal choice for chromatography applications. The Polyacrylamide segment is also expected to grow at a steady pace due to its high resolution and binding capacity. Overall, the Affinity Chromatography Market is expected to grow at a significant rate in the coming years, driven by the increasing demand for affinity chromatography techniques in the pharmaceutical and biotechnology industries. The market is also expected to benefit from the growing adoption of affinity chromatography in proteomics and genomics research. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Affinity Chromatography Market Application Insights** The Affinity Chromatography Market is segmented into Biomolecule Purification and Chromatographic Separation. Biomolecule Purification held the largest share of the market in 2023 and is projected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing demand for biomolecules for therapeutic, diagnostic, and research applications. The Chromatographic Separation segment is expected to witness a steady growth rate during the forecast period, owing to its wide range of applications in various industries, such as pharmaceuticals, food and beverage, and environmental monitoring. **Affinity Chromatography Market End User Insights** The end user segment of the Affinity Chromatography Market is categorized into pharmaceutical and biotechnology companies, research institutes, and academic institutions. Pharmaceutical and biotechnology companies account for the largest share of the market due to their extensive use of affinity chromatography for drug discovery and development. For instance, in 2023, the pharmaceutical and biotechnology segment held a 55% share of the Affinity Chromatography Market revenue. Research institutes are another significant end user, utilizing affinity chromatography for basic research and biomarker discovery. Academic institutions also contribute to the market growth by employing affinity chromatography for teaching and research purposes. The increasing demand for personalized medicine and the development of novel therapeutic modalities are expected to drive the growth of the Affinity Chromatography Market among these end users. **Affinity Chromatography Market Regional Insights** The regional market segmentation of the Affinity Chromatography Market provides insights into the performance of the market across different geographic regions. North America is expected to hold a significant market share due to the presence of major pharmaceutical and biotechnology companies. Europe is another key region, driven by government funding for research and development activities. The APAC region is expected to witness substantial growth in the coming years, as countries like China and India invest heavily in healthcare infrastructure. South America and MEA are relatively smaller markets but present opportunities for growth as healthcare systems expand in these regions. The Affinity Chromatography Market revenue is projected to grow significantly in the coming years, with each region contributing to the overall market growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Affinity Chromatography Market Key Players and Competitive Insights:** Major players in the Affinity Chromatography Market are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolios, and forming strategic partnerships. Leading Affinity Chromatography Market players are focused on developing innovative products that meet the evolving needs of their customers. The Affinity Chromatography Market is expected to witness significant growth in the coming years, driven by the increasing demand for high-throughput and cost-effective purification methods. Bio-Rad Laboratories, Inc. is a leading provider of life science research and clinical diagnostic products. The company offers a wide range of affinity chromatography products, including resins, columns, and kits. Bio-Rad's products are used in a variety of applications, including protein purification, antibody production, and drug discovery. The company has a strong global presence and is well-positioned to capitalize on the growing demand for affinity chromatography products. Thermo Fisher Scientific Inc. is another major player in the Affinity Chromatography Market. The company offers a comprehensive portfolio of affinity chromatography products, including resins, columns, and kits. Thermo Fisher's products are used in a variety of applications, including protein purification, antibody production, and drug discovery. The company has a strong global presence and is well-positioned to capitalize on the growing demand for affinity chromatography products. **Key Companies in the Affinity Chromatography Market Include:** **Affinity Chromatography Market Developments** _The rising prevalence of chronic diseases, increasing demand for biopharmaceuticals, and technological advancements in affinity chromatography are key factors driving market growth._ _Recent news developments include:_ _In February 2023, Merck KGaA launched a new affinity chromatography resin, MabSelect Xtra, for efficient monoclonal antibody purification._ _In March 2023, Thermo Fisher Scientific introduced a new line of prepacked affinity chromatography columns designed for high-throughput protein purification._ _These developments indicate the ongoing innovation and demand for advanced affinity chromatography solutions in the global market._ **Affinity Chromatography Market Segmentation Insights** **Affinity Chromatography Market Product Type Outlook** **Affinity Chromatography Market Application Outlook** **Affinity Chromatography Market End User Outlook** **Pharmaceutical and Biotechnology Companies** **Affinity Chromatography Market Regional Outlook** ## Market Drivers ### Regulatory Support and Compliance 亲和色谱市场受益于制药和生物技术行业日益增加的监管支持和合规要求。监管机构强调在生物制药生产中需要严格的质量控制措施，这推动了可靠纯化技术的采用。 亲和色谱因其能够满足这些监管标准而受到认可，确保治疗产品的安全性和有效性。随着法规变得更加严格，公司可能会投资于先进的色谱解决方案以保持合规。这一趋势预计将有助于亲和色谱市场的增长，因为组织寻求在遵守监管要求的同时增强其运营能力。 ### Rising Demand in Biopharmaceuticals 亲和色谱市场受到生物制药需求上升的显著影响，生物制药在治疗各种疾病中的应用日益增加。随着生物制药行业的扩展，对高效纯化方法的需求变得至关重要。亲和色谱因其能够选择性地分离蛋白质、抗体和其他生物分子而受到青睐，这些都是药物开发中必不可少的。 预计到2026年，生物制药市场将达到5000亿美元，进一步推动对亲和色谱解决方案的需求。这一趋势表明该行业的强劲增长轨迹，因为公司寻求可靠且可扩展的纯化技术以满足不断发展的医疗保健环境的需求。 ### Growing Focus on Personalized Medicine 亲和色谱市场越来越受到对个性化医疗日益关注的影响，个性化医疗根据个体患者的特征量身定制治疗。这种方法需要开发特定的生物分子，如单克隆抗体，这需要高效的纯化方法。亲和色谱在这一过程中发挥着至关重要的作用，使得高纯度产品的分离成为可能，这对个性化治疗至关重要。 预计到2030年，个性化医疗市场将达到2.5万亿美元，对亲和色谱解决方案的需求预计将相应上升。这一趋势突显了色谱在支持开发改善患者结果的靶向疗法中的重要性。 ### Increased Research and Development Activities 亲和色谱市场受到各个行业（包括制药、生物技术和学术机构）研发活动增加的推动。随着组织在研发上投资以创新和开发新的治疗解决方案，对先进纯化技术的需求上升。 亲和色谱因其在分离目标分子方面的精确性和效率而受到认可，成为实验室的首选。预计到2025年，全球研发投资将超过2万亿美元，这为亲和色谱市场提供了有利环境。这一资金的涌入可能会刺激色谱技术的进步，从而增强其在不同研究领域的应用。 ### Technological Advancements in Affinity Chromatography 亲和色谱市场正在经历技术进步的激增，这些进步提高了分离过程的效率和有效性。高通量筛选和自动化系统等创新正在简化工作流程，从而减少与纯化相关的时间和成本。新型配体和树脂的引入也提高了特异性和产量，这对生物制药应用至关重要。 因此，预计该市场在未来几年将以约8%的年复合增长率（CAGR）增长，受这些进步的推动。此外，人工智能和机器学习在色谱系统中的集成可能会优化操作参数，从而在研究和生产环境中带来更好的结果。 ## Future Outlook 亲和色谱市场预计在2025至2035年间以5.48%的复合年增长率增长，推动因素包括对生物制药的需求增加和分离技术的进步。 **New opportunities:** - 开发新型亲和配体以增强特异性 到2035年，市场预计将实现强劲增长，巩固其在生物加工领域的地位。 ## Segment Insights ### 按产品类型：配体类型（最大）与基质类型（增长最快） 在亲和色谱市场中，配体类型占据最大的市场份额，其特点是提高分离效率和精确性的关键作用。各种配体配置满足不同的应用需求，增强了它们对最终用户的吸引力。相比之下，基质类型正经历快速增长，因为对提高分辨率和通量的先进材料的需求不断增加。该细分市场的动态特性受到技术进步的推动，这些进步增强了特定于亲和分离过程的材料能力。 配体类型：（主导）与基质类型：（新兴） 配体类型被认为是亲和色谱市场中的主导细分市场，专注于优化与目标生物分子的相互作用的工程化配体。它们在各种生物技术应用中的重要角色推动了制药和生物技术行业的需求。与此同时，基质类型作为一个新兴的关键参与者，利用材料特性和表面改性方面的创新来提高分离效率。基质载体的适应性有助于它们在各种应用中的日益接受，使其成为不断发展的色谱领域中的重要组成部分。随着这两个细分市场的发展，它们的相互依赖将塑造未来的市场趋势。 ### 按应用：生物分子纯化（最大）与色谱分离（增长最快） 在亲和色谱市场中，应用细分主要分为生物分子纯化和色谱分离。生物分子纯化占据最大的市场份额，受到对单克隆抗体和其他治疗蛋白的需求上升的推动，这些蛋白需要高纯度水平。相反，色谱分离正经历快速增长，因为各行业越来越多地采用这些技术进行复杂混合物分析和特定组分分离，使其成为市场中的关键参与者。 应用：生物分子纯化（主导）与色谱分离（新兴） 生物分子纯化是亲和色谱市场中的主导细分市场，因其在药物开发和生化研究中的重要作用。该细分市场专注于提取和纯化生物化合物，确保它们符合严格的质量标准。相比之下，色谱分离虽然是新兴的，但由于其在制药、食品加工和环境监测等各种应用中的多功能性，正在迅速获得关注。随着企业在产品开发中追求效率和特异性，预计色谱分离技术将在提高多个行业的生产力和有效性方面发挥越来越重要的作用。 ### 按最终用户：制药和生物技术公司（最大）与研究机构（增长最快） 在亲和色谱市场中，最终用户的分布显示出制药和生物技术公司占据显著主导地位，拥有最大的市场份额。它们的采用受到研发投资增加和药物发现与开发中对有效纯化技术需求的推动。与此同时，研究机构作为一个新兴细分市场，满足对创新研发解决方案的需求，增强了它们在预测期内的市场存在。 制药和生物技术公司（主导）与研究机构（新兴） 制药和生物技术公司在亲和色谱市场中占据主导地位，因为它们在药物开发和生产过程中的重要作用。它们对生物制药研究的广泛资金支持和对个性化医疗应用的重视进一步增强了它们的市场影响力。相反，研究机构被视为一个新兴细分市场，受到学术研究需求和与行业合作伙伴的合作推动。它们促进色谱技术的创新，并专注于小众应用，从而满足特定的研究需求，并逐渐扩大在这一竞争激烈的市场中的立足点。 ## Regional Market Share Analysis ### 北美：创新与市场领导 北美是亲和色谱市场最大的市场，约占全球市场份额的45%。该地区的增长受到对生物制药需求增加、生物技术进步和支持性监管框架的推动。赛默飞世尔科技和生物瑞德实验室等主要参与者的存在进一步推动了市场扩张，同时研究和开发的投资也在上升。 美国在北美市场中处于领先地位，其次是加拿大，加拿大的生物制药生产正在激增。竞争格局的特点是成熟公司和新兴初创企业的混合，专注于创新解决方案和技术。关键参与者正在投资于战略合作伙伴关系和合作，以增强其市场存在和产品供应。 ### 欧洲：监管支持与增长 欧洲是亲和色谱市场的第二大市场，约占全球市场份额的30%。该地区受益于严格的监管标准，促进高质量生物制药的生产。对医疗保健和生物技术的投资增加，以及对个性化医疗的日益关注，是市场增长的关键驱动因素。欧洲药品管理局的指南也支持该行业的创新。 德国和英国是该市场的领先国家，法国和瑞士也有显著贡献。竞争格局的特点是默克KGaA和萨托里乌斯AG等主要参与者的存在，他们积极参与研究和开发。行业与学术界之间的合作正在促进创新，增强该地区在全球市场中的地位。 ### 亚太地区：快速增长与投资 亚太地区的亲和色谱市场正在快速增长，约占全球市场份额的20%。该地区的扩展受到对生物技术投资增加、医疗保健支出上升和对药物开发日益关注的推动。中国和印度等国正在崛起为关键参与者，受到有利的政府政策和旨在增强医疗基础设施的倡议的支持。 中国是该地区最大的市场，其次是日本和印度，这些国家也在生物制药研究方面进行大量投资。竞争格局正在演变，本地和国际公司都在争夺市场份额。安捷伦科技和沃特斯公司等关键参与者正在扩大在该地区的业务，促进市场的整体增长。 ### 中东和非洲：未开发的潜力与增长 中东和非洲地区在亲和色谱市场中逐渐崭露头角，约占全球市场份额的5%。增长主要受到对医疗保健和生物技术投资增加的推动，以及对先进诊断技术需求的上升。各国政府正专注于改善医疗基础设施，预计这将催化未来几年的市场增长。 南非和阿联酋在该地区的市场中处于领先地位，在生物制药和研究倡议方面进行了大量投资。竞争格局的特点是本地和国际参与者的混合，企业正在探索合作伙伴关系以增强其市场存在。随着该地区的持续发展，亲和色谱的增长机会预计将显著扩大。 ## Competitive Benchmarking 亲和色谱市场的主要参与者不断努力通过投资研发、扩展产品组合和形成战略合作伙伴关系来获得竞争优势。领先的亲和色谱市场参与者专注于开发满足客户不断变化需求的创新产品。预计亲和色谱市场将在未来几年见证显著增长，推动因素是对高通量和具有成本效益的纯化方法的需求增加。   生物瑞德实验室公司是生命科学研究和临床诊断产品的领先供应商。该公司提供广泛的亲和色谱产品，包括树脂、柱和试剂盒。生物瑞德的产品用于多种应用，包括蛋白质纯化、抗体生产和药物发现。该公司在全球范围内拥有强大的市场存在，并且在满足对亲和色谱产品日益增长的需求方面处于良好位置。   赛默飞世尔科技公司是亲和色谱市场的另一主要参与者。该公司提供全面的亲和色谱产品组合，包括树脂、柱和试剂盒。赛默飞的产品用于多种应用，包括蛋白质纯化、抗体生产和药物发现。该公司在全球范围内拥有强大的市场存在，并且在满足对亲和色谱产品日益增长的需求方面处于良好位置。 ## Recent News & Developments **在2026年4月，**默克KGaA推出了第二条下一代蛋白A树脂系列，增强了其在抗体捕获领域的地位，这是最大的亲和色谱应用。MilliporeSigma，默克KGaA在美国和加拿大的生命科学业务，宣布已完成收购。该交易将Amsphere蛋白A树脂和蛋白A色谱能力纳入其下游产品组合，以实现可扩展的抗体纯化。（来源：[globenewswire.com](https://www.globenewswire.com/news-release/2026/04/01/3266549/0/en/MilliporeSigma-Completes-Acquisition-of-JSR-Life-Sciences-Chromatography-Business-Expanding-Protein-A-Capabilities-and-Downstream-Portfolio.html)） **在2026年9月，**这表明一个关键参与者正在朝着GMP准备的预装下游柱迈进，从而降低客户的包装和资格负担。 注意：这些是离子交换和混合模式树脂，而不是亲和树脂。我仅将其作为相邻色谱发展的内容。生物瑞德的产品新闻列表将公告日期定为2026年9月1日。生物瑞德推出了预装的过程规模Foresight Pro柱，填充其Nuvia树脂，涵盖阴离子交换、阳离子交换和混合模式化学。每个柱子均来自单一生产批次，而不是混合树脂批次。（来源：[technologynetworks.com](https://www.technologynetworks.com/drug-discovery/product-news/bio-rad-launches-new-process-scale-chromatography-columns-416192)） **在2025年9月，**这是市场历史领导者对亲和树脂成本和生产力的直接举措。Cytiva宣布了新的蛋白A亲和树脂，用于抗体捕获步骤。它表示，在临床场景中，与传统的MabSelect SuRe LX树脂相比，每克单克隆抗体的消耗成本可以降低超过30%。（来源：[cytivalifesciences.com](https://www.cytivalifesciences.com/en/us/about-us/newsroom/cytiva-advances-resins-portfolio)） ## Report Scope | 2024年市场规模 | 49.53（亿美元） | | --- | --- | | 2025年市场规模 | 52.24（亿美元） | | 2035年市场规模 | 89.09（亿美元） | | 复合年增长率（CAGR） | 5.48%（2025 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 亿美元 | | 主要公司简介 | 市场分析正在进行中 | | 覆盖的细分市场 | 市场细分分析正在进行中 | | 主要市场机会 | 生物制药的进步推动对创新亲和色谱市场解决方案的需求。 | | 主要市场动态 | 对生物制药的需求上升推动亲和色谱市场的创新和竞争。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 亲和色谱市场目前的估值是多少？** A: 亲和色谱市场在2024年的估值为49.53亿美元。 **Q: 到2035年，亲和色谱市场的预计市场规模是多少？** A: 预计到2035年，市场将达到89.09亿美元。 **Q: 在预测期内，亲和色谱市场的预期年均增长率是多少？** A: 预计2025年至2035年间，市场的年均增长率为5.48%。 **Q: 哪些公司被视为亲和色谱市场的关键参与者？** A: 关键参与者包括赛默飞世尔科技、GE医疗、默克KGaA和Bio-Rad实验室。 **Q: 亲和色谱市场的主要产品类型是什么？** A: 主要产品类型包括配体型和基质型，2024年的估值均为24.765亿美元。 **Q: 哪些应用推动了亲和色谱市场的发展？** A: 关键应用包括生物分子纯化和色谱分离，2024年的估值均为24.765亿美元。 **Q: 亲和色谱的主要终端用户是谁？** A: 主要终端用户包括制药和生物技术公司、研究机构和学术机构。 **Q: 2024年制药和生物技术公司的估值是多少？** A: 制药和生物技术公司的估值在2024年为24.76亿美元。 **Q: 到2035年，研究机构的市场预计将增长多少？** A: 研究机构的市场预计将从2024年的14.76亿美元增长到2035年的26.46亿美元。 **Q: 哪些趋势正在影响亲和色谱市场的增长？** A: 趋势包括纯化技术的进步和生物制药行业需求的增加。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/affinity-chromatography-market-29074*